Nina C. Leksa

766 total citations
16 papers, 538 citations indexed

About

Nina C. Leksa is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Nina C. Leksa has authored 16 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hematology and 3 papers in Immunology. Recurrent topics in Nina C. Leksa's work include Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Nina C. Leksa is often cited by papers focused on Hemophilia Treatment and Research (6 papers), Platelet Disorders and Treatments (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Nina C. Leksa collaborates with scholars based in United States, France and Austria. Nina C. Leksa's co-authors include Thomas Schwartz, Kasper R. Andersen, Stephen G. Brohawn, Kanagalaghatta R. Rajashankar, Eric D. Spear, Robert Peters, Kevin E. Knockenhauer, Xianchi Dong, Timothy A. Springer and Qi Lü and has published in prestigious journals such as Science, Blood and Proteins Structure Function and Bioinformatics.

In The Last Decade

Nina C. Leksa

15 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina C. Leksa United States 8 391 91 69 52 43 16 538
Lorna Wilkinson‐White Australia 12 352 0.9× 77 0.8× 103 1.5× 100 1.9× 26 0.6× 25 528
Sankaranarayanan Srinivasan United States 10 217 0.6× 75 0.8× 72 1.0× 26 0.5× 38 0.9× 11 381
Vanesa Fernández‐Sáiz Germany 14 494 1.3× 41 0.5× 157 2.3× 39 0.8× 60 1.4× 20 609
Yukiko Sato Japan 10 206 0.5× 41 0.5× 57 0.8× 23 0.4× 51 1.2× 16 386
Stanisław K. Jóźwiakowski United Kingdom 15 745 1.9× 32 0.4× 68 1.0× 111 2.1× 12 0.3× 17 813
Stephen M. Manzella United States 12 456 1.2× 51 0.6× 133 1.9× 93 1.8× 135 3.1× 17 652
Georgi L. Lukov United States 10 292 0.7× 104 1.1× 50 0.7× 27 0.5× 126 2.9× 17 458
B B Rosenblum United States 12 211 0.5× 77 0.8× 34 0.5× 103 2.0× 48 1.1× 15 501
Scott Simanski United States 14 400 1.0× 28 0.3× 79 1.1× 60 1.2× 36 0.8× 22 487
E. Soravia United States 7 339 0.9× 68 0.7× 56 0.8× 33 0.6× 98 2.3× 7 584

Countries citing papers authored by Nina C. Leksa

Since Specialization
Citations

This map shows the geographic impact of Nina C. Leksa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina C. Leksa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina C. Leksa more than expected).

Fields of papers citing papers by Nina C. Leksa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina C. Leksa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina C. Leksa. The network helps show where Nina C. Leksa may publish in the future.

Co-authorship network of co-authors of Nina C. Leksa

This figure shows the co-authorship network connecting the top 25 collaborators of Nina C. Leksa. A scholar is included among the top collaborators of Nina C. Leksa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina C. Leksa. Nina C. Leksa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhou, Shan, Laurie D. Smith, Elena Kistanova, et al.. (2025). Novel transferrin receptor-mediated enzyme replacement therapy efficiently treats myogenic and neurogenic aspects of Pompe disease in mice. Molecular Therapy — Methods & Clinical Development. 33(3). 101547–101547.
2.
Muliaditan, Morris, Tamara J. van Steeg, Lindsay B. Avery, et al.. (2025). Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery of antibodies. mAbs. 17(1). 2515414–2515414. 1 indexed citations
3.
Rajagopal, Vaishnavi, Nina C. Leksa, Ronald D. Gorham, et al.. (2023). SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb. Blood Advances. 7(16). 4258–4268. 5 indexed citations
4.
Fuller, James R., Kevin E. Knockenhauer, Nina C. Leksa, Robert Peters, & Joseph D. Batchelor. (2021). Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy. Blood. 137(21). 2970–2980. 27 indexed citations
5.
Wang, Shaobin, et al.. (2020). Reducing Antithrombin in Plasma to Levels Observed in Fitusiran-Treated Patients Does Not Interfere with Coagulation Assays. Blood. 136(Supplement 1). 10–10. 1 indexed citations
6.
Dong, Xianchi, Nina C. Leksa, Ekta Seth Chhabra, et al.. (2019). The von Willebrand factor D′D3 assembly and structural principles for factor VIII binding and concatemer biogenesis. Blood. 133(14). 1523–1533. 56 indexed citations
7.
Leksa, Nina C., et al.. (2019). Intrinsic differences between FVIIIa mimetic bispecific antibodies and FVIII prevent assignment of FVIII‐equivalence. Journal of Thrombosis and Haemostasis. 17(7). 1044–1052. 24 indexed citations
8.
Li, Wenjing, Jianxin Hu, Nina C. Leksa, et al.. (2018). A Novel Humanized Hemophilia-a Mouse Model to Facilitate Preclinical In Vivo Studies of Human Specific Fviiia-Mimetic Bispecific Antibodies. Blood. 132(Supplement 1). 2458–2458. 1 indexed citations
9.
Aleman, Maria M., et al.. (2018). Phospholipid-Independent Activity of Fviiia Mimetic Bispecific Antibodies in Plasma. Blood. 132(Supplement 1). 2461–2461. 2 indexed citations
10.
Leksa, Nina C., Po‐Lin Chiu, George M. Bou-Assaf, et al.. (2017). The structural basis for the functional comparability of factor VIII and the long‐acting variant recombinant factor VIII Fc fusion protein. Journal of Thrombosis and Haemostasis. 15(6). 1167–1179. 9 indexed citations
11.
Knockenhauer, Kevin E., et al.. (2016). Systematic Protein–Protein Interaction Analysis Reveals Intersubcomplex Contacts in the Nuclear Pore Complex. Molecular & Cellular Proteomics. 15(8). 2594–2606. 6 indexed citations
12.
Andersen, Kasper R., Nina C. Leksa, & Thomas Schwartz. (2013). Optimized E. coli expression strain LOBSTR eliminates common contaminants from His-tag purification.. PubMed. 81(11). 1857–61. 1 indexed citations
13.
Andersen, Kasper R., Nina C. Leksa, & Thomas Schwartz. (2013). OptimizedE. coliexpression strain LOBSTR eliminates common contaminants from His‐tag purification. Proteins Structure Function and Bioinformatics. 81(11). 1857–1861. 168 indexed citations
14.
Leksa, Nina C. & Thomas Schwartz. (2010). Membrane-coating lattice scaffolds in the nuclear pore and vesicle coats. Nucleus. 1(4). 314–318. 16 indexed citations
15.
Leksa, Nina C., Stephen G. Brohawn, & Thomas Schwartz. (2009). The Structure of the Scaffold Nucleoporin Nup120 Reveals a New and Unexpected Domain Architecture. Structure. 17(8). 1082–1091. 51 indexed citations
16.
Brohawn, Stephen G., Nina C. Leksa, Eric D. Spear, Kanagalaghatta R. Rajashankar, & Thomas Schwartz. (2008). Structural Evidence for Common Ancestry of the Nuclear Pore Complex and Vesicle Coats. Science. 322(5906). 1369–1373. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorna Wilkinson‐White Breakdown of academic impact, for papers by Sankaranarayanan Srinivasan Breakdown of academic impact, for papers by Vanesa Fernández‐Sáiz Breakdown of academic impact, for papers by Yukiko Sato Breakdown of academic impact, for papers by Stanisław K. Jóźwiakowski Breakdown of academic impact, for papers by Stephen M. Manzella Breakdown of academic impact, for papers by Georgi L. Lukov Breakdown of academic impact, for papers by B B Rosenblum Breakdown of academic impact, for papers by Scott Simanski Breakdown of academic impact, for papers by E. Soravia
Rankless by CCL
2026